Long-Term Cilta-Cel Follow-Up Shows Curative Potential in Pretreated Multiple Myeloma
Written by
Cancer Network
Published
0
comments
0
min
Cilta-cel shows promising long-term efficacy in treating relapsed/refractory multiple myeloma, with significant survival rates and manageable safety profiles.